SCHEMBL31474259

SCHEMBL31474259

CNC(=O)c1ncc(N2CCNCC2)s1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 8/20 0.53
HDAC2 Q92769 6/20 0.53
KCNH2 Q12809 1/20 0.49
MAPK8 P45983 1/20 0.40
MAPK9 P45984 1/20 0.40
MAPK10 P53779 1/20 0.40
LMNA P02545 1/20 0.40
THRB P10828 1/20 0.40
HDAC6 Q9UBN7 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
BMPR1B O00238 1/20 0.36
ACVRL1 P37023 1/20 0.36
ACVR1 Q04771 1/20 0.36
RIPK2 O43353 1/20 0.36
TAAR1 Q96RJ0 1/20 0.35
IKBKB O14920 1/20 0.35
AOC3 Q16853 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29215321 0.99 HDAC3 (0.52) HDAC3HDAC2KCNH2MAPK8MAPK9
SCHEMBL30695510 0.81 HDAC3 (0.40) HDAC3HDAC2KCNH2LMNATHRB
SCHEMBL23560975 0.76 HDAC6 (0.55) HDAC3HDAC2MAPK8MAPK9MAPK10
SCHEMBL31474329 0.75 HDAC2 (0.56) HDAC3HDAC2KCNH2HDAC6
Hydrochloric Acid SCHEMBL29215320 0.74 HDAC2 (0.54) HDAC3HDAC2KCNH2HDAC6
SCHEMBL30898853 0.74 TPSAB1 (0.34) HDAC3HDAC2KCNH2MAPK8MAPK9
SCHEMBL27122851 0.73 PARP1 (0.47) HDAC3HDAC2KCNH2MAPK8MAPK9
SCHEMBL29115584 0.71 HDAC3 (0.54) HDAC3HDAC2KCNH2HDAC6
SCHEMBL30542912 0.71 HDAC3 (0.54) HDAC3HDAC2KCNH2HDAC6
SCHEMBL20181688 0.70 HDAC3 (1.00) HDAC3HDAC2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250346573-A1 AZAQUINOLINONE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF CHENGDU EASTON BIOPHARMACEUTICALS CO LTD (CN) 2025-11-13 US disclosed
EP-4534533-A1 AZAQUINOLINONE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF Chengdu Easton Biopharmaceuticals Co., Ltd. (CN) 2025-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250346573-A1 AZAQUINOLINONE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF PARP1, PARP8, PARP11 HDAC3 1400/4885HDAC2 482/4885KCNH2 4555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.